Page 97 - 南京医科大学自然版
P. 97

第44卷第11期       王彦涵,张     莱,王 君,等. 心房颤动伴中度及以上心房功能性二尖瓣反流患者的临床特征[J].
                 2024年11月                    南京医科大学学报(自然科学版),2024,44(11):1558-1564                      ·1563 ·


                                                    表3 多因素Logistic回归分析
                                             Table 3 Multivariate logistic regression analysis

                                Variable                       OR                 95%CI                  P
                    Age                                        0.975            0.921-1.033             0.397
                    CHA2DS2⁃VASc score                         1.111            0.888-1.389             0.358
                    Renal insufficiency                        2.250            0.908-5.575             0.080
                    Persistent atrial fibrillation             0.835            0.303-2.299             0.726
                    NOAC                                       0.386            0.144-1.036             0.059
                    Serum creatinine                           0.995            0.980-1.010             0.485
                    eGFR                                       0.991            0.962-1.020             0.520
                    NT⁃proBNP                                  1.000            1.000-1.000             0.522
                    HFpEF                                      1.038            0.395-2.731             0.939
                    Course of atrial fibrillation              0.949            0.879-1.024             0.178
                    Rhythm control drug                        0.912            0.329-2.529             0.859
                    Catheter ablation                          0.000            0.000-0.000             0.999
                    Heart rate control medication              1.656            0.267-10.259            0.588
                    Mild⁃to⁃moderate tricuspid regurgitation   6.571            1.362-31.705            0.019
                    Moderate tricuspid regurgitation          10.795            3.816-30.543           <0.001
                    Moderate⁃to⁃severe tricuspid regurgitation  19.525          4.593-82.999           <0.001
                    Severe tricuspid regurgitation            20.701            5.799-73.896           <0.001
                    LAD                                        1.067            1.002-1.137             0.044
                    LVEDd                                      1.153            1.052-1.264             0.002
                    LVEF                                       0.952            0.892-1.016             0.140
                   Tricuspid regurgitation was subject to no tricuspid regurgitation+mild tricuspid regurgitation as the reference.
                反流、较大的左心房与左心室时应积极治疗,防止                                 Asian Cardiovasc Thorac Ann,2020,28(7):421-426
                AFMR进一步恶化。本研究为单中心观察性研究,研                         [5] OKURA H,TAKADA Y,YAMABE A,et al. Prevalence
                究对象为住院患者,病情较严重,可能具有选择偏倚;                               and correlates of physiological valvular regurgitation in
                入组患者中仅4例患者无三尖瓣反流,故Logistic 回                           healthy subjects[J]. Circ J,2011,75(11):2699-2704
                归分析中将三尖瓣无反流患者与三尖瓣轻度反流                            [6] JANUARY C T,WANN L S,CALKINS H,et al. 2019
                                                                       AHA/ACC/HRS focused update of the 2014 AHA/ACC/
                患者合并作为参照。后期课题组将继续增加样本
                                                                       HRS guideline for the management of patients with atrial
                量,并追踪随访数据,以求获得更加客观、全面的研
                                                                       fibrillation:a report of the American college of cardiology/
                究结果。
                                                                       american heart association task force on clinical practice
               [参考文献]                                                  guidelines and the heart rhythm society in collaboration
                                                                       with the society of thoracic surgeons[J]. Circulation,
               [1] VIRANI S S,ALONSO A,BENJAMIN E J,et al. Heart
                                                                       2019,140(2):125-151
                    disease and stroke statistics ⁃ 2020 update:a report from
                                                                 [7] DOLDI P,STOLZ L,ORBAN M,et al. Transcatheter mi⁃
                    the American heart association[J]. Circulation,2020,141
                                                                       tral valve repair in patients with atrial functional regurgi⁃
                   (9):e139-e596
                                                                       tation[J]. JACC Cardiovasc Imaging,2022,15(11):
               [2] LORING Z,CLARE R M,HOFMANN P,et al. Natural
                    history of echocardiographic changes in atrial fibrillation:  1843-1851
                                                                 [8] MACHINO⁃OHTSUKA T,SEO Y,ISHIZU T,et al. Effica⁃
                    a case ⁃ controlled study of longitudinal remodeling[J].
                    Heart Rhythm,2024,21(1):6-15                       cy ,safety ,and outcomes of catheter ablation of atrial
               [3] DEFERM S,BERTRAND P B,VERBRUGGE F H,et al.          fibrillation in patients with heart failure with preserved
                    Atrial functional mitral regurgitation:JACC review topic  ejection fraction[J]. J Am Coll Cardiol,2013,62(20):
                    of the week[J]. J Am Coll Cardiol,2019,73(19):2465-  1857-1865
                    2476                                         [9] ROTTLÄNDER D,GOLABKESH M,DEGEN H,et al.
               [4] FAN Y T,WAN S,WONG R H,et al. Atrial functional mi⁃  Mitral valve edge ⁃ to ⁃ edge repair versus indirect mitral
                    tral regurgitation:mechanisms and surgical implications[J].  valve annuloplasty in atrial functional mitral regurgita⁃
   92   93   94   95   96   97   98   99   100   101   102